New Drug Approvals Archive - March 2004
Iquix (levofloxacin ophthalmic) Ophthalmic Solution
Date of Approval: March 1, 2004
Treatment for: Corneal Ulcers
Iquix (levofloxacin) is a topical fluoroquinolone indicated for the treatment of bacterial corneal ulcers.
Sensipar (cinacalcet) Tablets
Date of Approval: March 8, 2004
Company: Amgen Inc.
Treatment for: Secondary Hyperparathyroidism, Hypercalcemia of Malignancy
Sensipar (cinacalcet) is a calcimimetic agent indicated for the treatment of secondary hyperparathyroidism in dialysis patients and for the treatment of hypercalcemia in patients with parathyroid carcinoma.
Read more: Sensipar (cinacalcet) FDA Approval History
Follistim AQ (follitropin beta) Injection
Date of Approval: March 24, 2004
Company: Organon USA Inc.
Treatment for: Female Infertility, Hypogonadism -- Male, Ovulation Induction
Follistim AQ (follitropin beta) is human follicle-stimulating hormone prescribed for women undergoing assisted reproductive treatments (ART) such as in vitro fertilization (IVF), and for the induction of ovulation to achieve pregnancy, and for men with hypogonadism.
New Dosage Form Approved: March 29, 2004